|
ORC5L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.89945886481291E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.36549999999003E-06 |
| Normal-vs-Stage2 |
2.010200E-02 |
| Normal-vs-Stage3 |
6.464000E-03 |
| Normal-vs-Stage4 |
3.186000E-02 |
| Stage1-vs-Stage2 |
4.760400E-01 |
| Stage1-vs-Stage3 |
4.598400E-01 |
| Stage1-vs-Stage4 |
9.647200E-01 |
| Stage2-vs-Stage3 |
9.579600E-01 |
| Stage2-vs-Stage4 |
6.024800E-01 |
| Stage3-vs-Stage4 |
6.843800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75929998241986E-09 |
| Normal-vs-AfricanAmerican |
2.430800E-04 |
| Normal-vs-Asian |
5.992400E-02 |
| Caucasian-vs-AfricanAmerican |
5.727600E-01 |
| Caucasian-vs-Asian |
4.995800E-01 |
| AfricanAmerican-vs-Asian |
6.784200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96780003403063E-09 |
| Normal-vs-Female |
4.07410000002884E-06 |
| Male-vs-Female |
2.673000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.335100E-03 |
| Normal-vs-Extreme_Weight |
7.80120000000162E-05 |
| Normal-vs-Obese |
7.576000E-04 |
| Normal-vs-Extreme_Obese |
2.031000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.275200E-01 |
| Normal_Weight-vs-Obese |
7.629600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.019600E-01 |
| Extreme_Weight-vs-Obese |
2.871000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.824400E-01 |
| Obese-vs-Extreme_Obese |
1.772840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.722400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.09249997937155E-09 |
| Normal-vs-Age(61-80Yrs) |
2.1476999999992E-05 |
| Normal-vs-Age(81-100Yrs) |
6.037200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.557400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.998200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.371600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.641840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.166000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.009200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.25766064229538E-12 |
| Normal-VS-Type2 PRCC |
6.439000E-03 |
| Normal-VS-KIRP CIMP |
4.800100E-02 |
| Normal-VS-Unclassified PRCC |
2.896100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.623800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.190600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.346200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.334600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.529400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.192200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.399800E-03 |
| Normal-vs-N1 |
7.240900E-04 |
| Normal-vs-N2 |
5.720000E-01 |
| N0-vs-N1 |
8.290000E-01 |
| N0-vs-N2 |
5.002600E-01 |
| N1-vs-N2 |
3.086200E-01 |
|
|
